FIELD: medicine; pharmacology.
SUBSTANCE: polypeptides under the invention include amino-acid sequence, structurally related sequence SEQ ID NO:1 resulted in the text of the description, to use of such polypeptides as immunogens, including as a part of compositions. The invention opens also expression systems for producing such polypeptides. The sequence SEQ ID NO:1 represents a truncated derivative of full-size polypeptide S. aureus. This full-size polypeptide is designated in the invention as full-size "ORF0657n". It is established, that the polypeptides described in the invention and containing amino-acid sequence are SEQ ID NO:1.
EFFECT: polypeptides cause protective immune response against staphylococcus aureus.
43 cl, 56 dwg, 4 tbl, 17 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUING 2,4-DIHYDROXYBUTYRATE | 2013 |
|
RU2645260C2 |
COMPOSITIONS AND METHODS FOR REDUCTION OF LEVEL OF HS IN FERMENTED BEVERAGES | 2008 |
|
RU2476590C2 |
VERSIONS OF ISOPRENE SYNTHASE APPLIED FOR IMPROVEMENT OF ISOPRENE PRODUCTION BY MICROORGANISMS | 2009 |
|
RU2516343C2 |
HEMOPOIETIC PROTEIN (VARIANTS), DNA SEQUENCE, METHOD FOR PREPARING HEMOPOIETIC PROTEIN, METHOD FOR SELECTIVE EXPANSION OF HEMOPOIETIC CELLS, METHOD FOR PRODUCING DENDRITIC CELLS, METHOD FOR STIMULATING FOR PRODUCING HEMOPOIETIC CELLS IN PATIENT, PHARMACEUTICAL COMPOSITION, METHOD FOR TREATMENT | 1997 |
|
RU2245887C2 |
COMPOSITIONS AND METHODS OF PRODUCING ISOPRENE | 2008 |
|
RU2545699C2 |
DNA CODING FULL-SIZE HUMAN INTERLEUKIN-RECEPTOR ANTAGONIST 36, DNA CODING FULL-SIZE HUMAN INTERLEUKIN-RECEPTOR ANTAGONIST 36 WITH C-END POLIGISTIDINE TAG, PLASMID EXPRESSION VECTOR (VERSIONS), ESCHERICHIA COLI BL21 [DE3] STAR (PET-IL36RAF),-PRODUCER OF FULL-SIZE RECEPTOR ANTAGONIST 36 AND STRAIN OF BACTERIA ESCHERICHIA COLI BL21 [DE3] STAR (PET-IL36RAF-HIS),-PRODUCER OF FULL-SIZE RECEPTOR ANTAGONIST 36 WITH C-END POLIGISTIDINE TAG | 2014 |
|
RU2582569C2 |
METHODS AND MATERIALS FOR RECOMBINANT PRODUCTION OF SAFFRON COMPOUNDS | 2012 |
|
RU2676730C2 |
EXPRESSING SYSTEM | 2001 |
|
RU2385348C2 |
STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS AND THEIR APPLICATION | 2011 |
|
RU2677140C1 |
STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS AND THEIR APPLICATION | 2011 |
|
RU2644237C2 |
Authors
Dates
2008-10-27—Published
2004-07-22—Filed